3M Innovative Properties Co. acquires and manages intellectual property right. It engages in the acquisition and ownership of the intellectual property rights to the products designed and manufactured by its parent company 3M Corporation. The company was founded on May 10, 1999 and is headquartered in Roseville, MN.

Shanghai Jahwa United Co., Ltd. (hereinafter referred to as "Shanghai Jahwa") is one of the oldest Chinese daily-used chemicals companies. It was previously known as Hong Kong Kwong Sang Hong, which is established in 1898. It was listed on Shanghai Stock Exchange in 2001 over more than 100 years of development. Shanghai Jahwa has attached great importance to the construction of self-owned brands, with several domestic famous brands such as "Herborist", "Liushen", "Maxam", "GF" and "GIVING". Facing the fierce competition from Chinese market, Jahwa has achieved outstanding results by adopting differentiated brand management strategies, making it a leader among numerous market segments.

STALICLA is a clinical stage, precision molecular neuroscience biotech company with a mature pipeline for patients with Neurodevelopmental Disorders (NDDs) and Neuropsychiatric disorders. STALICLA’s unique approach addresses a principal weakness in the drug development process for NDD’s and neuropsychiatric disorders: behavior is a terrible biomarker. Clinical psychiatric and neurodevelopmental diagnoses encompass a broad diversity of underlying biology. This has contributed to drug development failure by diluting true responders in a population of patients with heterogeneous biology. STALICLA’s technology platform, DEPI, discovers biologically based endophenotypes within classical neuropsychiatric diagnostic groups. The AI/ML engine converges molecular data with human genetic information and non-behavioral clinical signs and symptoms, to define biologically related subgroups and create testable clinical hypotheses related to that biology. The DEPI platform has already completed several successful clinical validations, through the identification and biological validation of two distinct subgroups of patients with Autism Spectrum Disorder, ASD-Phenotype1 and ASD-Phenotype2, together with their predicted tailored treatment candidates (STP1 and STP2); as well as the blindly and retrospective calling “high” responder patients to previously failed drug candidates with high specificity, sensitivity, and positive predictive value. Further the completion of STP1 Phase 1b in 2022, STP1 will enter clinical Phase 2 in 2023; as well as STP2, a Phase 2 ready asset in licensed in Q4 ’22. Additionally, STALICLA will be advancing STP7, a recently in-licensed Phase 3 ready asset from Novartis, with strong potential for a neuropsychiatric indication, and whose clinical development will be fully financed by a non-dilutive funding to be announced in Feb. STALICLA is currently preparing its next stage of growth, to advance its pipelines and to scale its platform towards revenue generation.

Verisign, Inc. is an American company based in Reston, Virginia, United States that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc and .tv country-code top-level domains, and the back-end systems for the .jobs, .gov, and .edu top-level domains. Verisign also offers a range of security services, including managed DNS, distributed denial-of-service (DDoS) attack mitigation and cyber-threat reporting.

Livzon Group Livzon Pharmaceutical Factory, a subsidiary of Livzon Pharmaceutical Group, Inc., is a company headquartered in China that produces and distributes Western and Chinese medicines, diet supplements, medical devices and chemical materials.

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 million cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.

Guangdong Yuyue Biotechnology Co., Ltd., established on 2016-01-04, Business scope includes production:Bacterial Inactivated Vaccine(For aquatic products),cytotoxic inactivated vaccine(For aquatic products),Yolk antibody;Veterinary drug production;Veterinary drug business;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;road freight transport(Does not contain dangerous goods);General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Zhonghua Paint (Shenzhen) Co., Ltd., established on 1991-10-21, Business scope includes general business items:paint sales(Free of Hazardous Chemicals);ink sales(Free of Hazardous Chemicals);Sales of Surface Functional Materials;Chemical product sales(No licensed chemical products);Sales of building materials;Sales of building decoration materials;New material technology research and development;Non-residential real estate leases;housing lease;Machinery and Equipment Leasing;Machinery sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:paint manufacturing;Hazardous Chemicals Management;Import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Hengshui Nuodun Biotechnology Co., Ltd., established on 2014-03-04, Business scope includes production and sales:disinfection products(Free of Hazardous Chemicals),medical instruments(Ikind,IIkind),air sterilizer,Space surface disinfection machine,water filter,Water purification products,Water sterilization material,Water antibacterial material,chemical indicator,biological indicator,electronic indicator,Air purification products,Sterilizer(Free of Hazardous Chemicals),Chlorine Dioxide Generator,Endoscope washer and disinfector,breathable membrane,plastic products,electronics,Protective Equipment,Packaging Materials,power supply,electronic product,daily necessities,Technology Development and Consulting,Import and export of goods or technology**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Livzon Pharmaceutical Group Inc. is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products. Livzon has 9 GMP production plants located in Guangdong, Shanghai, Sichuan, Fujian, 3 plantation bases for Chinese drug preparation production located in Shanxi, Gansu, Yunan of China, with more than 5,700 employees. Livzon has modern industrial chain and product group, operates to manufacture drug preparation, bulk medicines and intermediates, as well as diagnostic reagents and equipment, with approximate 280 products therapeutically grouped as gastrointestinal, cardio-cerebral-vascular, anti-biotic, gonadotropic hormone etc. Meanwhile, Livzon possesses production bases as leading manufacturer of Chinese drug preparation injection, and specialist bulk medicines and intermediates such as fermented antibiotics, sterile cephalosporins, and hypolipidemic “statins”.

Shinryo Corp engages in the design, supervision and construction of facility construction related to air conditioning, plumbing, sanitation, electricity and telecommunications. The company was founded by Masaru Kagami on February 23, 1959 and is headquartered in Tokyo, Japan.

3M Medical Devices & Materials Manufacturing Shanghai Co. Ltd., a subsidiary of 3M Co., is a Chinese company located in Shanghai. The firm designs, manufactures and sells medical equipment and instruments.

Shaanxi Chemical Research Institute Co., Ltd., established on 1993-03-05, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Industrial Engineering Design Services;Oil and Gas Technical Services;Engineering and Technology Research and Experimental Development;New material technology research and development;Engineering Management Services;Industrial Design Services;Research and development of unconventional water source utilization technology;Solid Waste Treatment;Chemical product sales(No licensed chemical products).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Beijing Kemufeng Biopharmaceutical Co., Ltd., established on 2012-04-23, The scope of business includes the production of veterinary drugs;sales of veterinary drugs;Bioengineering technology development;technology development,transfer,consult,Serve;Sales of medical devices(Ι,Class II),Instrumentation;Import and export;Technology Import and Export;Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;and items that are legally subject to approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Zhaofenghua Biotechnology (Fuzhou) Co., Ltd., established on 2003-05-26, Business scope includes technical development of biological products,Technical Services,Technology Transfer and Technology Consulting;Medical Research and Experimental Development;Agricultural Science Research and Experimental Development;Biopharmaceutical Manufacturing;Genetically engineered drugs and vaccine manufacturing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

CJ Corporation (Korean: 씨제이㈜) is a South Korean conglomerate holding company headquartered in Seoul. It comprises numerous businesses in various industries of food and food service, pharmaceutics and biotechnology, entertainment and media, home shopping and logistics. CJ Group was originally a branch of Samsung until it separated in the 1990s.